The Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.

Oncol Res · 2026 · PMC13126603 · PMID 42065071

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among 1005 randomized patients, atezolizumab significantly improved DFS in stage II–IIIA cases with PD-L1 ≥1%, particularly those with PD-L1 ≥50%, while results in the overall intent-to-treat (ITT) population did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.